# EDGAR Filing Document

**Accession Number:** 0001505065
**File Stem:** 0001171843-25-005856
**Filing Date:** 2025-9
**Character Count:** 6574
**Document Hash:** 9fac4f742c8711f7a092cd734ef84306
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001171843-25-005856.hdr.sgml**: 20250911

**ACCESSION NUMBER**: 0001171843-25-005856

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250911

**FILED AS OF DATE**: 20250911

**DATE AS OF CHANGE**: 20250911

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Brainsway Ltd.
- **CENTRAL INDEX KEY:** 0001505065
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35165
- **FILM NUMBER:** 251308461

**BUSINESS ADDRESS:**
- **STREET 1:** 16 HARTUM STREET RAD TOWER, 14TH FLOOR
- **STREET 2:** Har HaHotzvim
- **CITY:** Jerusalem
- **STATE:** L3
- **ZIP:** 9777516
- **BUSINESS PHONE:** 972 2 581-3140

**MAIL ADDRESS:**
- **STREET 1:** 16 HARTUM STREET RAD TOWER, 14TH FLOOR
- **STREET 2:** Har HaHotzvim
- **CITY:** Jerusalem
- **STATE:** L3
- **ZIP:** 9777516

**UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION<br> Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES** **EXCHANGE ACT OF 1934**

**For the month of September 2025**

Commission File Number: **001-35165**

**B** **RAINSWAY LTD.**

(Translation of registrant's name into English)

**16 Hartum Street RAD Tower, 14th Floor** 

**Har HaHotzvim**

**Jerusalem, 9777516, Israel**

**(+972-2) 582-** **4030**

(Address and telephone number of Registrant's principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

This Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on April 22, 2019 (Registration No. 333- 230979) and the Company's Registration Statements on Form F-3 filed with the Securities and Exchange Commission on July 22, 2024 (Registration No. 333-280934) and on April 22, 2025 (Registration No. 333-286672).

**CONTENTS**

***Results of Annual Shareholder Meeting***

At the Annual General Meeting of Shareholders of BrainsWay Ltd. (the "**Company**") held on September 11, 2025, a quorum of votes being duly represented, <u>all</u> proposed resolutions were approved by the respective required majority of the shareholders. Below are the proposals which were adopted, as well as the respective share of support each resolution received:

&nbsp;&nbsp;&nbsp;&nbsp;**1.** (1)
 To appoint Kost Forer Gabbay & Kasierer, certified public accountants in Israel and a
 member of Ernst & Young Global, as the Company's independent auditors for the year
 2025 and for an additional period until the next annual general meeting and to authorize
 the Board of Directors to determine their compensation for the year.

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Votes in Favor** | &nbsp;&nbsp;**Votes Against** | &nbsp;&nbsp;**Abstentions** |
| &nbsp;&nbsp;19439247 | &nbsp;&nbsp;3274 | &nbsp;&nbsp;163044 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) To approve the election or re-election of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Mr. Ami Boehm as a director on the Board of Directors of the Company until the next annual general meeting.

---

| | | |
|:---|:---|:---|
| **Votes in Favor** | **Votes Against** | **Abstentions** |
| 19,237,930 | 197,327 | 170,308 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Dr. David Zacut as a director on the Board of Directors of the Company until the next annual general meeting.

---

| | | |
|:---|:---|:---|
| **Votes in Favor** | **Votes Against** | **Abstentions** |
| 19,068,147 | 373,014 | 162,968 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Ms. Eti Mitrany as a director on the Board of Directors of the Company until the next annual general meeting.

---

| | | |
|:---|:---|:---|
| **Votes in Favor** | **Votes Against** | **Abstentions** |
| 19,164,813 | 275,464 | 164,852 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Ms. Karen Sarid as a director on the Board of Directors of the Company until the next annual general meeting.

---

| | | |
|:---|:---|:---|
| **Votes in Favor** | **Votes Against** | **Abstentions** |
| 19,165,697 | 275,464 | 163,968 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Prof. Avraham Zangen as a director on the Board of Directors of the Company until the next annual general meeting.

---

| | | |
|:---|:---|:---|
| **Votes in Favor** | **Votes Against** | **Abstentions** |
| 19,070,493 | 370,668 | 163,968 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Mr. Avner Lushi as a director on the Board of Directors of the Company until the next annual general meeting.

---

| | | |
|:---|:---|:---|
| **Votes in Favor** | **Votes Against** | **Abstentions** |
| 19,126,386 | 313,731 | 165,012 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) Mr. Jonathan Shulkin as a director on the Board of Directors of the Company until the next annual general meeting.

---

| | | |
|:---|:---|:---|
| **Votes in Favor** | **Votes Against** | **Abstentions** |
| 19,246,402 | 195,195 | 163,968 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) to approve the update in compensation and the grant of equity compensation to Mr. Hadar Levy, the Company's Chief Executive Officer, on the terms described in the Proxy Statement, and to determine that it is for the benefit of the Company.

---

| | | |
|:---|:---|:---|
| **Votes in Favor** (excluding shareholders indicating personal interest, if any) | **Votes Against** | **Abstentions** |
| 19,381,439 | 53,206 | 170,920 |

---

**Signatures**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>Date: September 11, 2025 | **BRAINSWAY LTD.**<br>By: /s/ *Ami Boehm*<br> ——————————————<br> Ami Boehm, Chairman of the Board of Directors |

---